Es-is develops novel enzyme-based syntheses for the high quality production of active pharmaceutical ingredients. Based on its proprietary technology, EnzyMatrix™, Es-is delivers patentable processes at an unprecedented short time-to-market.
Chemo-enzymatic production allows pharmaceutical companies and API manufacturers to cut down on production costs, reduce the use of environmental pollutants, and improve purity and yield.
Es-is has developed a revolutionary, proprietary technology to scan tens of thousands of known natural enzymes, select and evaluate promising candidates using an innovative in-house database and highly accurate quantum-mechanical calculations. EnzyMatrix™ can further optimize the activity, specificity and stability of the selected enzyme via active-site engineering.